Morpholine → HCID 89813599, compound
Reaction equation
P([O-])([O-])([O-])=O.[K+].[K+].[K+].[Br:9][C:10]1[CH:15]=[CH:14][C:13]([C:16]([F:19])([F:18])[F:17])=[CH:12][C:11]=1F.O1CCOCC1.[NH:27]1[CH2:32][CH2:31][O:30][CH2:29][CH2:28]1>C(Cl)Cl.CN(C=O)C>[Br:9][C:10]1[CH:15]=[CH:14][C:13]([C:16]([F:19])([F:18])[F:17])=[CH:12][C:11]=1[N:27]1[CH2:32][CH2:31][O:30][CH2:29][CH2:28]1Participants
7
Conditions
- Temperature
- 150 °C
Procedure
A microwave vial charged with potassium phosphate (0.533 g, 2.51 mmol), 1-bromo-2-fluoro-4-(trifluoromethyl)benzene (0.610 g, 2.51 mmol) and 1 mL dioxane, was treated with morpholine (0.437 ml, 5.02 mmol) and was heated to 150° C. in a microwave reactor for one hour. LC/MS showed mostly starting material, so the reaction mixture was treated with 1 mL DMF and was heated to 150° C. in an oil bath overnight. LC/MS showed product, so the reaction mixture was diluted with DCM, filtered through a syringe filter, and concentrated. Purification of the resulting residue by silica gel column chromatography (0 to 50% EtOAc/heptane) gave 4-(2-bromo-5-(trifluoromethyl)phenyl)morpholine (0.280 g, 0.903 mmol) as a clear oil. [M+H]+=312.0
Workup
- temperaturewas heated to 150° C. in an oil bath overnight
- filtrationfiltered through a syringe
- filtrationfilter
- concentrationconcentrated
- customPurification of the resulting residue by silica gel column chromatography (0 to 50% EtOAc/heptane)
Sources & evidence
- ORD record
- ord-8836d701547545d09b8dcd4542e9f5a6
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09051311B2
Reaction notes
Loading…